Compare Adaptive Biotechnologies Corp (ADPT) vs KE Holdings Inc (BEKE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Adaptive Biotechnologies Corp vs KE Holdings Inc — how do they compare? Adaptive Biotechnologies Corp trades at $25.5 (market cap $4.04B), while KE Holdings Inc trades at $17.27 (market cap $18.92B). The key difference: KE Holdings Inc is far larger — about 4.7× Adaptive Biotechnologies Corp's market cap, and KE Holdings Inc pays a 1.63% dividend while Adaptive Biotechnologies Corp pays none. Which is the better fit depends on your goals.
| ADPT | BEKE | |
|---|---|---|
Market Cap | $4.04B | $18.92B |
Sector | Health | Technology |
52-Week High | $25.45 | $20.36 |
52-Week Low | $12.30 | $14.26 |
Enterprise Value | $4.10B | $14.66B |
Dividend Yield | — | 1.63% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Adaptive Biotechnologies Corp
Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers.
Read more on ADPT →About KE Holdings Inc
KE Holdings (Beike) is China’s leading platform for housing transactions and services. It operates the Lianjia brand and uses data-driven technology to facilitate home sales, rentals, and home renovation services.
Read more on BEKE →
